KR20050101205A - Process for preparing pyridine-substituted amino ketal derivatives - Google Patents
Process for preparing pyridine-substituted amino ketal derivatives Download PDFInfo
- Publication number
- KR20050101205A KR20050101205A KR1020057014743A KR20057014743A KR20050101205A KR 20050101205 A KR20050101205 A KR 20050101205A KR 1020057014743 A KR1020057014743 A KR 1020057014743A KR 20057014743 A KR20057014743 A KR 20057014743A KR 20050101205 A KR20050101205 A KR 20050101205A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- hydroxide
- acetylpyridine
- chloride
- sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/51—Acetal radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Abstract
Description
본 발명은 화학식 I의 피리디닐-치환된 디알콕시아미노에탄 유도체를 제조하는 방법 및 본 발명에 따른 방법의 중간체를 제공한다. The present invention provides a process for the preparation of pyridinyl-substituted dialkoxyaminoethane derivatives of the formula (I) and the intermediates of the process according to the invention.
화학식 I의 화합물은 약제학적 활성 성분의 제조의 중간체이다. 예를 들어, 미국 특허 제5,792,871호에는, 피리딘 라디칼이 3-위치에서 치환되고 R'이 (C1-C3)-알킬인 화학식 I의 화합물의 유도체의 합성이 기재되어 있다. 미국 특허 제5,792,871호에 따르면, 이들 유도체로부터 화학식 II의 화합물을 수득할 수 있다.Compounds of formula (I) are intermediates in the preparation of pharmaceutically active ingredients. For example, US Pat. No. 5,792,871 describes the synthesis of derivatives of compounds of formula I wherein the pyridine radical is substituted in the 3-position and R 'is (C 1 -C 3 ) -alkyl. According to US Pat. No. 5,792,871, compounds of formula II can be obtained from these derivatives.
또한, 화학식 I의 화합물은 빌딩 블럭(building block)으로서 화학식 III의 피리디노이미다졸 유도체를 제조하는 데 사용된다(J. Am. Soc., 1938, 753-755).The compounds of formula (I) are also used to prepare pyridinimidazole derivatives of formula (III) as building blocks (J. Am. Soc., 1938, 753-755).
위의 화학식 III에서, R"은 H, SH이다.In formula (III) above, R ″ is H, SH.
화학식 III의 피리디노이미다졸 유도체는 신규한 마크롤라이드 항생제, 예를 들어, 텔리트로마이신(미국특허 제5,635,485호)을 제조하는 데 사용되었다. Pyridinoimidazole derivatives of formula III have been used to prepare novel macrolide antibiotics, for example, telitthromycin (US Pat. No. 5,635,485).
화학식 I의 화합물을 제조하는 공지된 방법은 알코올 용액 중의 케톡심의 p-톨루엔설폰산 에스테르에 대한 알칼리 금속 알콕사이드의 작용, 예를 들어, 화학식 I의 아미노 케탈 유도체가 아미노 케톤환의 제조 시 중간체로서 작용하는 것이다[참조: F.moller: amine durch Umlagerungsreaktionen(Neber-Umlagerung) [Amines by rearrangement reactions(Neber rearrangement)], Houben-Weyl 11/1: Stickstoffverbindungen II [Nitrogen compounds II](1957), p. 903-905].Known methods of preparing compounds of formula (I) include the action of alkali metal alkoxides on p-toluenesulfonic acid esters of ketoxime in alcoholic solutions, for example, amino ketal derivatives of formula (I) acting as intermediates in the preparation of amino ketone rings. F.moller: amine durch Umlagerungsreaktionen (Neber-Umlagerung) [Amines by rearrangement reactions (Neber rearrangement)], Houben-Weyl 11/1: Stickstoffverbindungen II [Nitrogen compounds II] (1957), p. 903-905.
화학식 I의 1-(피리디닐)-1,1-디알콕시-2-아미노에탄 유도체의 제조가 하기 3 단계 공정에 의한 화학식 IV의 1-(3-피리디닐)-1,1-디에톡시-2-아미노에탄 디하이드로클로라이드의 실시예를 사용하여 미국 특허 제5,792,871호에 기재되어 있다:Preparation of the 1- (pyridinyl) -1,1-dialkoxy-2-aminoethane derivative of the formula (I) is carried out by the following three step process: 1- (3-pyridinyl) -1,1-diethoxy- of the formula (IV) It is described in US Pat. No. 5,792,871 using an example of 2-aminoethane dihydrochloride:
이 방법에서, 화학식 V의 3-아세틸피리딘을 메탄올 중의 하이드록실암모늄 클로라이드로 초기에 옥심화한다. 용매 교체를 사용하여 수득된 화학식 VI의 3-아세틸피리딘 옥심을 피리딘으로 전환시키고 다수의 증류 공정 및 추가의 피리딘 첨가로 건조시킨다(물 함량 < 5몰%).In this process, 3-acetylpyridine of formula V is initially oxime with hydroxylammonium chloride in methanol. The 3-acetylpyridine oxime of formula VI obtained using solvent replacement is converted to pyridine and dried by a number of distillation processes and further pyridine addition (water content <5 mol%).
대안적으로, 옥심화는 피리딘에서 직접적으로 수행하고, 동일한 방법으로 건조시킨다. 그 후, 수득된 화학식 VI의 3-아세틸피리딘 옥심의 하이드로클로라이드와 피리딘의 혼합물을 화학식 VII의 토실 클로라이드와 반응시켜 화학식 VIII의 3-아세틸피리딘 토실 옥심을 수득하고 물을 사용하여 혼합물로부터 침전시키고 분리한다.Alternatively, oximelation is carried out directly in pyridine and dried in the same way. Thereafter, the obtained mixture of hydrochloride of 3-acetylpyridine oxime of formula VI and pyridine is reacted with tosyl chloride of formula VII to obtain 3-acetylpyridine tosyl oxime of formula VIII, precipitated from the mixture with water and separated. do.
그 후, 수득된 화학식 VIII의 토실 옥심을 네버 전위(Neber rearrangement)로 에탄올 중의 칼륨 에톡사이드와 반응시켜 아미노 케탈을 수득한다. 수득된 p-톨루엔설폰산 칼륨 염을 메틸 3급-부틸 에테르로 희석한 후, 여과하고, 여과된 용액을 에테르에 용해된 염화수소와 혼합한다. 이로써, 화학식 IV의 1-(3-피리디닐)-1,1-디에톡시-2-아미노에탄 디하이드로클로라이드가 오렌지색 고체로 침전된다. The tosyl oxime of formula (VIII) is then reacted with potassium ethoxide in ethanol at Never rearrangement to yield an amino ketal. The resulting p-toluenesulfonic acid potassium salt is diluted with methyl tert-butyl ether, then filtered and the filtered solution is mixed with hydrogen chloride dissolved in ether. This precipitates 1- (3-pyridinyl) -1,1-diethoxy-2-aminoethane dihydrochloride of formula IV as an orange solid.
미국 특허 제5,792,871호에 따르면, 분리된 생성물의 순도는 1H 및 13C NMR 데이타로 측정하여 미확인 불순물의 결과로 > 95%이다. 추가의 반응을 위해, 아미노 케탈 디하이드로클로라이드(IV)를 물에 현탁시키고 수산화나트륨 용액과 혼합하여 추가의 커플링 반응에 유리 염기로서 필요한 아미노 케탈을 제조한다.According to US Pat. No. 5,792,871, the purity of the isolated product is> 95% as a result of unidentified impurities as determined by 1 H and 13 C NMR data. For further reactions, amino ketal dihydrochloride (IV) is suspended in water and mixed with sodium hydroxide solution to prepare the amino ketals required as free base for further coupling reactions.
상기 기재된 공정은 산업적으로 대규모화될 때 몇 가지 단점을 갖는다: 첫번째, 각 단계에서 수득되는 중간체를 증류 공정으로 건조시켜야만 한다. 두번째, 화학식 VIII의 3-아세틸피리딘 토실 옥심 중간체는 실온에서 연장 저장시 매우 쉽게 분해되어 다량의 에너지(3-아세틸피리딘 토실 옥심의 분해 에너지 약 1000 J/g)를 방출하고, 또한, 톨루엔 설폰산 케톡심 에스테르의 저장에 관하여 문헌[참조: F.moller: amine durch Umlagerungsreaktionen(Neber-Umlagerung), Houben-Weyl 11/1: Stickstoffverbindungen II(1957), p. 903-905]에 기재되어 있다. 세번째, 이 방법으로 제조된 1-(3-피리디닐)-1,1-디에톡시-2-아미노에탄 디하이드로클로라이드(IV)는 부산물에 의해 오염되고, 이는 강한 착색에 의해 확인된다. 네번째, 유리 1-(3-피리디닐)-1,1-디에톡시-2-아미노에탄을 수득하기 위하여, 분리된 염(IV)을 추가의 공정에서 보조 염기와 함께 방출해야 한다. 다섯번째, 공정 동안에 잦은 용매 교체가 있다. 그 후, 환경 오염을 야기하는 용매 혼합물을 다시 매우 비싸게 후처리해야 한다. The process described above has several disadvantages when scaled up industrially: First, the intermediate obtained in each step must be dried by a distillation process. Second, the 3-acetylpyridine tosyl oxime intermediate of formula VIII is very easily decomposed upon extended storage at room temperature to release a large amount of energy (about 1000 J / g of 3-acetylpyridine tosyl oxime), and also toluene sulfonic acid Regarding storage of ketoxime esters, see F. moller: amine durch Umlagerungsreaktionen (Neber-Umlagerung), Houben-Weyl 11/1: Stickstoffverbindungen II (1957), p. 903-905. Third, 1- (3-pyridinyl) -1,1-diethoxy-2-aminoethane dihydrochloride (IV) prepared by this method is contaminated by byproduct, which is confirmed by strong coloring. Fourth, to obtain free 1- (3-pyridinyl) -1,1-diethoxy-2-aminoethane, the isolated salt (IV) must be released with the auxiliary base in a further process. Fifth, there are frequent solvent changes during the process. Thereafter, the solvent mixture which causes environmental pollution must be worked up again very expensively.
본 발명의 목적은 보다 효과적이고 안전하게 화학식 I의 화합물을 합성하는 방법을 찾는 것이다. It is an object of the present invention to find a method for synthesizing a compound of formula I more effectively and safely.
따라서, 본 발명은, R1 및 R2는 각각 독립적으로 (C1-C6)-알킬이고, 여기서, 알킬 그룹은 직쇄 또는 측쇄일 수 있거나, R1 및 R2는 산소 원자와 함께 R1 및 R2가 함께 (C2-C4)-알킬리덴 그룹인 케탈환을 형성하고, 여기서, 피리딘 라디칼은 2-, 3- 또는 4-위치, 바람직하게는 3-위치에서 치환되는 화학식 I의 1-피리딜-1,1-디알콕시-2-아미노에탄 유도체를 제조하는 방법을 제공하고, 당해 제조 방법은 하이드록실암모늄 화합물의 수성 용액(예를 들어, 하이드록실암모늄 클로라이드 또는 하이드록실암모늄 설페이트) 또는 하이드록실아민의 수성 용액을 사용하고 Mn+을 포함하는 무기 염기를 첨가하여 화학식 V의 아세틸피리딘을 화학식 IX의 아세틸피리딘 옥심 금속 염(여기서, n은 1 또는 2이고, Mn+은 n이 1인 경우, 알칼리 금속 또는 n이 2인 경우, 알칼리 토금속 이온이고, 바람직하게는 Li+, Na+, K+ 또는 Ca2+이다)으로 전환하는 공정 단계(a)를 포함한다.Thus, in the present invention, R 1 and R 2 are each independently (C 1 -C 6 ) -alkyl, wherein the alkyl group may be straight or branched, or R 1 and R 2 together with the oxygen atom are R 1 And R 2 together form a ketal ring wherein (C 2 -C 4 ) -alkylidene group, wherein the pyridine radical is substituted in the 2-, 3- or 4-position, preferably in the 3-position Provided is a method for preparing a 1-pyridyl-1,1-dialkoxy-2-aminoethane derivative, which method comprises an aqueous solution of a hydroxylammonium compound (eg, hydroxylammonium chloride or hydroxylammonium sulfate). ) Or by using an aqueous solution of hydroxylamine and adding an inorganic base comprising M n + to convert the acetylpyridine of formula V to the acetylpyridine oxime metal salt of formula IX, wherein n is 1 or 2 and M n + is n If 1, alkali metal or if n is 2, alkaline earth In an ion, and preferably it includes a process comprising: conversion with Li +, Na +, a K + or Ca 2+) (a).
R1 및 R2는 바람직하게은 각각 (C1-C6)-알킬 라디칼이다. 특히 바람직하게은 R1 및 R2가 동일하고 각각 (C1-C6)-알킬 라디칼이다. (C1-C6)-알킬은, 예를 들어, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸 또은 n-헥실이다.R 1 and R 2 are each preferably a (C 1 -C 6 ) -alkyl radical. Especially preferably R 1 and R 2 are the same and each is a (C 1 -C 6 ) -alkyl radical. (C 1 -C 6 ) -alkyl is, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl or n-hexyl.
(C2-C4)-알킬리덴 그룹을 포함하은 케탈환은, 예를 들어, [1,3]디옥살란 또는 [1,3]디옥산 라디칼이다.The ketal ring containing a (C 2 -C 4 ) -alkylidene group is, for example, a [1,3] dioxalan or [1,3] dioxane radical.
제조는 단일 또는 다중성분 계량에 의한 배취방식으로 또는 연속적으로 수행할 수 있다. 화학식 IX의 화합물은 분리되거나 용액 또는 현탁액으로서 추가 공정을 갖을 수 있다. The preparation can be carried out either batchwise or continuously by single or multicomponent metering. Compounds of formula (IX) may be isolated or have additional processes as solutions or suspensions.
Mn+은, 예를 들어, Li+, Na+, K+ 또는 Ca2+이다. Mn+을 포함하는 무기 염기는, 예를 들어, 알칼리 금속 또는 알칼리 토금속 수산화물, 알칼리 금속 또는 알칼리 토금속 탄산화물 또는 알칼리 금속 또는 알칼리 토금속 하이드로젠카보네이트 또는 이의 혼합물, 바람직하게는 수산화리튬, 수산화나트륨, 수산화칼륨, 수산화칼슘, 탄산나트륨, 탄산수소나트륨 또는 탄산칼륨이다.M n + is, for example, Li + , Na + , K + or Ca 2+ . Inorganic bases comprising M n + are, for example, alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal carbonates or alkali metal or alkaline earth metal hydrogencarbonates or mixtures thereof, preferably lithium hydroxide, sodium hydroxide, hydroxide Potassium, calcium hydroxide, sodium carbonate, sodium bicarbonate or potassium carbonate.
아세틸피리딘 100몰 당 바람직하게는 하이드록실아민 또는 하이드록실암모늄 화합물 98 내지 120몰, 보다 바람직하게는 99 내지 101몰; 및 M+을 포함하는 무기 염기 200 내지 300몰, 보다 바람직하게는 200 내지 220몰, 또는 M2+을 포함하는 무기 염기 100 내지 150몰, 보다 바람직하게는 100 내지 110몰을 사용한다.Preferably 98 to 120 moles, more preferably 99 to 101 moles of hydroxylamine or hydroxylammonium compound per 100 moles of acetylpyridine; And 200 to 300 moles of inorganic base comprising M + , more preferably 200 to 220 moles, or 100 to 150 moles of inorganic base comprising M 2+ , more preferably 100 to 110 moles.
공정 단계(b)에서, 화학식 IX의 아세틸피리딘 금속 염의 수성 용액, 수성 현탁액 또는 분리된 고체를 수불혼화성, 수난용성 또는 수불용성의 적합한 용매에서 이탈 그룹 Y를 포함하는 p-톨루엔설폰산 유도체(X)의 용액과 물과 적합한 용매의 2상 혼합물에서의 임의로 하나 이상의 상 전이 촉매, 예를 들어, 4급 암모늄 또는 포스포늄 염, 바람직하게는 화학식 XII의 4급 암모늄 염 또는 화학식 XIII의 포스포늄 염; 또는 화학식 XII 또는 화학식 XIII의 수화물을 사용하여 반응시켜 화학식 IX의 아세틸피리딘 금속 염을 수득한다.In process step (b), p-toluenesulfonic acid derivatives comprising the leaving group Y in an aqueous solution, aqueous suspension or separated solid of an acetylpyridine metal salt of formula IX in a water immiscible, poorly water soluble or water insoluble solvent ( Optionally one or more phase transfer catalysts, for example quaternary ammonium or phosphonium salts, preferably quaternary ammonium salts of formula XII or phosphonium of formula XIII, in a biphasic mixture of water and a suitable solvent salt; Or by reacting with a hydrate of formula (XII) or (XIII) to obtain an acetylpyridine metal salt of formula (IX).
위의 화학식 X에서,In Formula X above,
Y는 F, Cl 또는 Br이고, 바람직하게는 Cl이다.Y is F, Cl or Br, preferably Cl.
위의 화학식 XII 및 XIII에서, In the above formulas XII and XIII,
R3 내지 R10은 동일하거나 상이하고 각각 독립적으로R 3 to R 10 are the same or different and each independently
a) 직쇄 또는 측쇄의 (C1-C20)-알킬,a) straight or branched (C 1 -C 20 ) -alkyl,
b) 벤질 또는b) benzyl or
c) 페닐이고,c) phenyl,
X-는 음이온, 예를 들어, 플루오라이드, 클로라이드, 브로마이드, 요오다이드, 하이드록사이드, 하이드로젠설페이트, 테트라플루오로보레이트, 아세테이트, 트리플루오로메탄설포네이트, 니트레이트, 헥사플루오로안티모네이트, 바람직하게는 메틸트리부틸암모늄 클로라이드이다.X − is an anion such as fluoride, chloride, bromide, iodide, hydroxide, hydrogensulfate, tetrafluoroborate, acetate, trifluoromethanesulfonate, nitrate, hexafluoroantimo Acetates, preferably methyltributylammonium chloride.
2상에서의 반응은 하나 이상의 상 전이 촉매를 사용하여 수행되는 것이 바람직하지만, 또한 상 전이 촉매 없이 수행된다. The reaction in two phases is preferably carried out using one or more phase transfer catalysts, but is also carried out without phase transfer catalysts.
공정 단계(b)는 배취방식으로 또는 연속적으로, 바람직하게는 연속적으로 영향을 받을 수 있고, 이 경우, 안전성 관점에서의 위험한 화학식 XI의 화합물의 농도는 낮게 유지된다. 그 후, 용매 및 수성 상의 수득된 혼합물은 통상적인 상 분리 방법을 사용하여 분리한다. 수성 상은 사용된, 용해된 금속 염을 포함한다. 수성 상은 생물학적 정화로 보내진다. 그 후, 임의로, 수성 상은 적합한 수 불용성 용매로 1회 이상 세척되고, 용매 상과 배합되고 함께 추가 반응 될 수 있다. 용매 상은 화학식 XI의 화합물을 포함한다. Process step (b) may be effected batchwise or continuously, preferably continuously, in which case the concentration of the dangerous compound of formula XI from the safety point of view is kept low. The resulting mixture of solvent and aqueous phase is then separated using conventional phase separation methods. The aqueous phase includes the dissolved metal salts used. The aqueous phase is sent to biological purification. Thereafter, the aqueous phase may optionally be washed one or more times with a suitable water insoluble solvent, combined with the solvent phase and further reacted together. The solvent phase comprises a compound of formula XI.
공정 단계(b)에서, 화학식 IX의 3-아세틸피리딘 옥심 염 100몰 당 0.1 내지 50몰, 바람직하게는 0.2 내지 10몰의 상 전이 촉매가 사용되는 것이 바람직하다.In process step (b), it is preferred to use from 0.1 to 50 moles, preferably from 0.2 to 10 moles of phase transfer catalyst per 100 moles of 3-acetylpyridine oxime salt of formula (IX).
화학식 XXII의 4급 암모늄 염의 예는 테트라메틸암모늄 브로마이드, 테트라메틸암모늄 클로라이드, 테트라에틸-암모늄 클로라이드, n-부틸트리에틸암모늄 클로라이드, 메틸트리이소프로필-암모늄 클로라이드, 메틸트리-n-부틸암모늄 클로라이드(Aliquat®175), 메틸트리-n-부틸암모늄 브로마이드, 메틸트리-n-부틸암모늄 하이드로젠설페이트, 메틸테트라-n-부틸암모늄 클로라이드, 메틸트리-n-옥틸-암모늄 클로라이드(Aliquat®336), 메틸트리-n-옥틸암모늄 하이드록사이드, 메틸트리카프릴암모늄 클로라이드, 메틸트리카프릴암모늄 하이드록사이드, 디메틸벤질(C8-C18)-알킬 클로라이드, 테트라-n-프로필암모늄 클로라이드, 트리에틸헥실암모늄 클로라이드, 트리에틸-n-옥틸암모늄 클로라이드, 트리에틸-n-옥틸암모늄 브로마이드, 트리에틸-n-데실암모늄 브로마이드, 트리에틸-n-헥사데실암모늄 브로마이드, 페닐트리에틸암모늄 클로라이드, 에틸트리-n-옥틸암모늄 브로마이드, 테트라-n-부틸암모늄 클로라이드, 테트라-n-부틸-암모늄 브로마이드, 테트라-n-부틸암모늄 클로라이드, 테트라-n-부틸-암모늄 하이드로젠설페이트, 테트라메틸암모늄 요오다이드, 테트라메틸-암모늄 하이드록사이드 펜타하이드레이트, 테트라메틸암모늄 하이드록사이드, 메틸트리에틸암모늄 브로마이드, 테트라메틸암모늄 클로라이드 모노하이드레이트, 테트라메틸암모늄 브로마이드, 테트라메틸암모늄 요오다이드, 테트라메틸암모늄 테트라플루오로보레이트, (n-헥실)트리메틸-암모늄 브로마이드, 페닐트리메틸암모늄 클로라이드, 페닐트리메틸-암모늄 요오다이드, 벤질트리메틸암모늄 클로라이드, 벤질트리메틸-암모늄 요오다이드, 벤질트리메틸암모늄 하이드록사이드, (n-옥틸)-트리메틸-암모늄 브로마이드, (N-노닐)트리메틸암모늄 브로마이드, 테트라-n-프로필-암모늄 브로마이드, 페닐트리에틸암모늄 요오다이드, (n-데실)트리메틸-암모늄 브로마이드, 벤질트리에틸암모늄 클로라이드, 벤질트리에틸-암모늄 브로마이드, 벤질트리에틸암모늄 테트라플루오로보레이트, 벤질-트리에틸암모늄 하이드록사이드, (n-도데실)트리메틸암모늄 클로라이드, (n-도데실)트리메틸암모늄 브로마이드, 벤질트리-n-프로필암모늄 클로라이드, 테트라-n-부틸암모늄 브로마이드, 테트라-n-부틸암모늄 요오다이드, 테트라-n-부틸암모늄 아세테이트, 테트라-n-부틸암모늄 하이드로젠설페이트, 테트라-n-부틸암모늄 하이드록사이드, 테트라-n-부틸암모늄 트리플루오로메탄-설포네이트, (n-테트라데실)-트리메틸암모늄 클로라이드, (n-테트라데실)트리메틸암모늄 브로마이드, (n-헥사데실)트리메틸-암모늄 브로마이드, 테트라-n-펜틸암모늄 클로라이드, 테트라-n-펜틸-암모늄 요오다이드, 벤질트리-n-부틸암모늄 클로라이드, 벤질트리-n-부틸-암모늄 브로마이드, (n-헥사데실)피리디늄 클로라이드 모노하이드레이트, (n-헥사데실)피리디늄 브로마이드 모노하이드레이트, 테트라-n-헥실암모늄 브로마이드, 테트라-n-헥실암모늄 하이드로젠설페이트, 테트라-n-옥틸-암모늄 브로마이드, 테트라-n-도데실암모늄 요오다이드 또는 테트라-n-도데실-암모늄 니트레이트이다.Examples of quaternary ammonium salts of formula XXII include tetramethylammonium bromide, tetramethylammonium chloride, tetraethyl-ammonium chloride, n-butyltriethylammonium chloride, methyltriisopropyl-ammonium chloride, methyltri-n-butylammonium chloride ( Aliquat® 175), methyltri-n-butylammonium bromide, methyltri-n-butylammonium hydrogensulfate, methyltetra-n-butylammonium chloride, methyltri-n-octyl-ammonium chloride (Aliquat® 336), methyl Tri-n-octylammonium hydroxide, methyltricaprylammonium chloride, methyltricaprylammonium hydroxide, dimethylbenzyl (C8-C18) -alkyl chloride, tetra-n-propylammonium chloride, triethylhexylammonium chloride Triethyl-n-octylammonium chloride, triethyl-n-octylammonium bromide, triethyl-n-decylammonium bromide, Triethyl-n-hexadecylammonium bromide, phenyltriethylammonium chloride, ethyltri-n-octylammonium bromide, tetra-n-butylammonium chloride, tetra-n-butyl-ammonium bromide, tetra-n-butylammonium chloride, Tetra-n-butyl-ammonium hydrogensulfate, tetramethylammonium iodide, tetramethyl-ammonium hydroxide pentahydrate, tetramethylammonium hydroxide, methyltriethylammonium bromide, tetramethylammonium chloride monohydrate, tetramethyl Ammonium bromide, tetramethylammonium iodide, tetramethylammonium tetrafluoroborate, (n-hexyl) trimethyl-ammonium bromide, phenyltrimethylammonium chloride, phenyltrimethyl-ammonium iodide, benzyltrimethylammonium chloride, benzyltrimethyl-ammonium Iodide, benzyl Trimethylammonium hydroxide, (n-octyl) -trimethyl-ammonium bromide, (N-nonyl) trimethylammonium bromide, tetra-n-propyl-ammonium bromide, phenyltriethylammonium iodide, (n-decyl) trimethyl- Ammonium bromide, benzyltriethylammonium chloride, benzyltriethyl-ammonium bromide, benzyltriethylammonium tetrafluoroborate, benzyl-triethylammonium hydroxide, (n-dodecyl) trimethylammonium chloride, (n-dodecyl) Trimethylammonium bromide, benzyltri-n-propylammonium chloride, tetra-n-butylammonium bromide, tetra-n-butylammonium iodide, tetra-n-butylammonium acetate, tetra-n-butylammonium hydrogensulfate, tetra -n-butylammonium hydroxide, tetra-n-butylammonium trifluoromethane-sulfonate, (n-tetradecyl) -trimethylarm Chloride, (n-tetradecyl) trimethylammonium bromide, (n-hexadecyl) trimethyl-ammonium bromide, tetra-n-pentylammonium chloride, tetra-n-pentyl-ammonium iodide, benzyltri-n-butylammonium Chloride, benzyltri-n-butyl-ammonium bromide, (n-hexadecyl) pyridinium chloride monohydrate, (n-hexadecyl) pyridinium bromide monohydrate, tetra-n-hexylammonium bromide, tetra-n-hexylammonium Hydrogensulfate, tetra-n-octyl-ammonium bromide, tetra-n-dodecylammonium iodide or tetra-n-dodecyl-ammonium nitrate.
화학식 XIII의 포스포늄 염의 예는 테트라-n-부틸-포스포늄 클로라이드, 테트라페닐포스포늄 브로마이드, 메틸트리-n-옥틸-포스포늄 클로라이드, 메틸트리페닐포스포늄 브로마이드, 에틸-트리-n-옥틸포스포늄 브로마이드, 테트라-n-부틸포스포늄 브로마이드, 테트라페닐포스포늄 클로라이드, 테트라페닐포스포늄 요오다이드, 테트라페닐포스포늄 헥사플루오로안티모네이트, 테트라페닐포스포늄 테트라플루오로보레이트, (n-헥사데실)트리-n-부틸포스포늄 브로마이드 또는 트리페닐메틸트리페닐포스포늄 클로라이드이다.Examples of phosphonium salts of formula (XIII) include tetra-n-butyl-phosphonium chloride, tetraphenylphosphonium bromide, methyltri-n-octyl-phosphonium chloride, methyltriphenylphosphonium bromide, ethyl-tri-n-octylphosph Phonium bromide, tetra-n-butylphosphonium bromide, tetraphenylphosphonium chloride, tetraphenylphosphonium iodide, tetraphenylphosphonium hexafluoroantimonate, tetraphenylphosphonium tetrafluoroborate, (n-hexa Decyl) tri-n-butylphosphonium bromide or triphenylmethyltriphenylphosphonium chloride.
수불혼화성, 수난용성 또는 수불용성인 적합한 용매는, 예를 들어, 치환되지 않거나 하나 이상의 (C1-C4)-알킬, 예를 들어, 메틸; 또는 불소, 염소 및 브롬으로 이루어진 그룹으로부터 선택된 하나 이상의 치환체에 의해 치환된 지방족 또는 방향족 탄화수소, 바람직하게는 톨루엔, 크실렌(순수 이성체 또는 이성체의 혼합물), 에틸벤젠, 헵탄 또는 디클로로메탄이다. 또한, 언급된 적합한 용매의 혼합물이 적합하다.Suitable solvents that are water immiscible, poorly water soluble, or water insoluble include, for example, unsubstituted or one or more (C 1 -C 4 ) -alkyl such as methyl; Or aliphatic or aromatic hydrocarbons substituted by one or more substituents selected from the group consisting of fluorine, chlorine and bromine, preferably toluene, xylene (a pure isomer or mixture of isomers), ethylbenzene, heptane or dichloromethane. Also suitable are mixtures of the suitable solvents mentioned.
p-톨루엔설폰산 유도체(X) 1몰 당 적합한 용매 0.6 내지 1.1kg을 사용하는 것이 바람직하다. 화학식 IX의 아세틸피리딘 옥심 염 100몰의 반응에서, p-톨루엔설폰산 유도체(X) 99 내지 150몰, 보다 바람직하게는 100 내지 110몰을 사용하는 것이 바람직하다. Preference is given to using from 0.6 to 1.1 kg of a suitable solvent per mole of p-toluenesulfonic acid derivative (X). In the reaction of 100 moles of the acetylpyridine oxime salt of formula (IX), it is preferable to use 99 to 150 moles, more preferably 100 to 110 moles of p-toluenesulfonic acid derivative (X).
용어 "2상 혼합물"은 두 액체 상-아세틸피리딘 옥심 염(IX)을 포함하는 수성 상 및 p-톨루엔설폰산 유도체(X)을 포함하는 용매 상-의 혼합물을 나타낸다. 상 전이 촉매가 사용되는 경우, 이는 수성 상 또는 용매 상에, 또는 두 상에 분리되어 존재할 수 있다. 2상 혼합물은 통상적인 배취방식 또는 연속적인 공정 운용에 의해 교반되고/되거나 혼합되어 상의 우수한 분산이 확보된다. The term "biphasic mixture" denotes a mixture of two liquid phases-an aqueous phase comprising acetylpyridine oxime salt (IX) and a solvent phase comprising p-toluenesulfonic acid derivative (X). If a phase transfer catalyst is used, it may be present in the aqueous phase or the solvent phase, or separately in two phases. The biphasic mixture is stirred and / or mixed by conventional batchwise or continuous process operation to ensure good dispersion of the phase.
공정 단계(b)의 반응 온도는 배취방식의 경우, 바람직하게는 0 내지 50℃, 보다 바람직하게는 5 내지 30℃이고, 연속적인 공정의 경우, 0 내지 60℃, 보다 바람직하게는 5 내지 40℃이다. The reaction temperature in process step (b) is preferably from 0 to 50 ° C., more preferably from 5 to 30 ° C., for batch processes, from 0 to 60 ° C., more preferably from 5 to 40 ° C. for continuous processes. ℃.
공정 단계(c)에서, 건조되거나 미리 건조되지 않은 화학식 XI의 아세틸피리딘 토실 옥심을 포함하는 용매 상을 알칼리 금속 알콕사이드, 알칼리 금속 하이드록사이드, 알칼리 토금속 알콕사이드 또는 알칼리 토금속 하이드록사이드와 알코올과의 혼합물에 계량함으로써 화학식 XI의 화합물을 화학식 I의 1-(피리디닐)-1,1-디알콕시-2-아미노-에탄 유도체로 전환시키고, 여기서, 알콕사이드는 R1O- 및/또는 R2O-이고, 알코올은 R1OH 및/또는 R2OH이고, R1 및 R2 화학식 I의 화합물에서 정의된 바와 같다.In process step (c), a mixture of an alkali metal alkoxide, alkali metal hydroxide, alkaline earth metal alkoxide or alkaline earth metal hydroxide with an alcohol is dried or the solvent phase comprising acetylpyridine tosyl oxime of formula XI which is not previously dried. by weighing a 1- (pyridinyl) of formula I a compound of formula XI -1,1- dialkoxy-2-amino-ethanol was converted to the derivative, wherein the alkoxide is R 1 O - and / or R 2 O - And the alcohol is R 1 OH and / or R 2 OH and R 1 and R 2 as defined for compounds of formula (I).
공정 단계(c)에서, 화학식 XI의 아세틸피리딘 토실 옥심 100몰 당 알칼리 금속 알콕사이드 99 내지 500몰, 보다 바람직하게는 100 내지 200몰; 알칼리 금속 하이드록사이드 99 내지 500몰, 보다 바람직하게는 100 내지 300몰; 알칼리 토금속 알콕사이드 50 내지 250몰, 보다 바람직하게는 50 내지 100몰; 또는 알칼리 토금속 하이드록사이드 50 내지 250몰, 보다 바람직하게는 50 내지 150몰을 사용하는 것이 바람직하다.In process step (c), 99 to 500 moles of alkali metal alkoxides, more preferably 100 to 200 moles per 100 moles of acetylpyridine tosyl oxime of formula (XI); 99 to 500 moles, more preferably 100 to 300 moles of alkali metal hydroxide; 50 to 250 moles, more preferably 50 to 100 moles of alkaline earth metal alkoxide; Or 50 to 250 moles, more preferably 50 to 150 moles, of alkaline earth metal hydroxides.
공정 단계(c)에서, 알칼리 금속 하이드록사이드 또는 알콕사이드, 특히 수산화리튬, 리튬 메톡사이드, 리튬 에톡사이드, 수산화나트륨, 나트륨 메톡사이드, 나트륨 에톡사이드, 수산화칼륨, 칼륨 메톡사이드, 칼륨 에톡사이드, 수산화세슘, 세슘 메톡사이드 또는 세슘 에톡사이드를 사용하는 것이 바람직하다.In process step (c), alkali metal hydroxides or alkoxides, in particular lithium hydroxide, lithium methoxide, lithium ethoxide, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium hydroxide, potassium methoxide, potassium ethoxide, hydroxide Preference is given to using cesium, cesium methoxide or cesium ethoxide.
알콕사이드 및/또는 알코올의 선택은 목적하는 알콕시 그룹의 도입에 따라 좌우된다. 예를 들어, 1-(피리디닐)-1,1-디메톡시-2-아미노에탄의 제조에서, 혼합물은 메탄올 중의 알칼리 금속 또는 알칼리 토금속 메톡사이드; 또는 메탄올 중의 알칼리 금속 하이드록사이드가 사용된다. R1 및 R2가 산소 원자와 함께 케탈환을 형성하는 화합물 1-(피리디닐)-1-([1,3]디옥살란)-2-아미노에탄의 제조에서, 예를 들어, 글리콜 중의 알칼리 금속 하이드록사이드가 사용된다.The choice of alkoxides and / or alcohols depends on the introduction of the desired alkoxy group. For example, in the preparation of 1- (pyridinyl) -1,1-dimethoxy-2-aminoethane, the mixture may be an alkali metal or alkaline earth metal methoxide in methanol; Or alkali metal hydroxides in methanol are used. In the preparation of compound 1- (pyridinyl) -1-([1,3] dioxalan) -2-aminoethane, wherein R 1 and R 2 together with the oxygen atom form a ketal ring, for example alkali in glycol Metal hydroxides are used.
화학식 XI의 아세틸피리딘 옥심 토실레이트 1몰 당 해당하는 알코올 0.3 내지 3kg, 바람직하게는 0.5 내지 1.5kg이 사용되는 것이 바람직하다. 전환은, 예를 들어, 0 내지 90℃, 보다 바람직하게는 10 내지 60℃의 온도 범위에서 영향을 받는다. It is preferred that 0.3 to 3 kg, preferably 0.5 to 1.5 kg, of the corresponding alcohol is used per mole of acetylpyridine oxime tosylate of formula (XI). The conversion is effected, for example, in a temperature range of 0 to 90 ° C, more preferably 10 to 60 ° C.
반응 후, 용매 부분을 초기에 증류시키고, 실온에서 p-톨루엔설폰산 염 부산물이 침전된다. 증류는 통상적인 방법으로 수행된다. 증류된 용매 혼합물은 공정 단계(c)에서 직접적으로 재사용할 수 있다.After the reaction, the solvent portion is initially distilled off and the p-toluenesulfonic acid salt by-product precipitates at room temperature. Distillation is carried out in a conventional manner. The distilled solvent mixture can be directly reused in process step (c).
p-톨루엔설폰산 알칼리 금속 또는 알칼리 토금속 염은 통상적인 여과 방법으로 제거된다. 남겨진 용매 분획은 대기압 또는 바람직하게는 감압하에 통상적인 방법으로 증류에 의해 제거된다.The p-toluenesulfonic acid alkali metal or alkaline earth metal salt is removed by conventional filtration methods. The remaining solvent fraction is removed by distillation in conventional manner under atmospheric pressure or preferably under reduced pressure.
그 후, 화학식 I의 아미노 케탈 유도체를 진공 증류 또는 정류, 또는 예미 증류로 스득된 증류 잔여물의 결정화에 의해 고 순도형으로 분리된다. 예를 들어, R1 및 R2가 각각 메틸인 화학식 I의 화합물은 증류에 의해 정제될 수 있다.Thereafter, the amino ketal derivatives of formula (I) are separated in high purity form by crystallization of the distillation residues obtained by vacuum distillation or rectification or by fine distillation. For example, compounds of formula I wherein R 1 and R 2 are each methyl can be purified by distillation.
진공 증류 또는 정류의 수율은 임의로 증류 잔여물에 융제를 가함으로써 향상시킬 수 있다. 용어 "융제"는 가열하면 점도가 감소하고, 따라서 증류될 잔여물의 유동성을 향상시키고 동시에 증류될 생성물보다 꽤 높은 비점을 갖는 액체 또는 왁스 고체를 뜻한다. 융제는, 예를 들어, 분자량이 400 이상인 폴리에틸렌 글리콜(예를 들어, 폴리에틸렌 글리콜 600 또는 폴리에틸렌 글리콜 1000), 파라핀(CnH2n+2, n > 15), 다가알코올(하나 이상의 OH 그룹을 갖는 알코올. 예를 들어, 글리세롤) 또는 에스테르, 예를 들어, 비스-2-에틸 세바케이트가 사용된다.The yield of vacuum distillation or rectification can be improved by optionally adding a flux to the distillation residue. The term "flux" means a liquid or wax solid that, when heated, decreases in viscosity, thus improving the flowability of the residue to be distilled and at the same time having a boiling point considerably higher than the product to be distilled. The flux may be, for example, polyethylene glycol having a molecular weight of at least 400 (eg, polyethylene glycol 600 or polyethylene glycol 1000), paraffin (C n H 2n + 2 , n> 15), polyhydric alcohol (having one or more OH groups Alcohols such as glycerol) or esters such as bis-2-ethyl sebacate are used.
결정화는 유기 용매를 사용하여 또는 사용하지 않고 통상적인 방법으로 수행될 수 있다. 녹임 또는 용매 공정이 사용될 수 있다.Crystallization can be carried out in conventional manner with or without organic solvents. Dissolving or solvent processes may be used.
본 발명에 따른 공정의 장점은, 첫번째, 유리 염기로서 고 순도의 화학식 I의 화합물의 직접적인 분리 및 매우 우수한 수율; 두번째, 선택된 반응 조건이, 안전성 관점에서 항상 화학식 XI의 중간체를 소량만 유발하고 안전성 관점에서 위험한 아세틸피리딘 토실 옥심을 고체로서 분리하지 않는 연속 공정으로 옥심화 및 토실화 반응으로 수행하도록 허하고, 따라서, 짧은 지연 시간 후, 직접적으로 연속 장치에서 안전성 관점에서 위험하지 않은 화학식 I의 아미노 케탈로 전환되는 것; 세번째, 고 순도(97% 이상) 및 수율(사용된 아세틸피리딘을 기준으로 하여, 75% 이상)의, 산업적 규모에 적합한 방법을 사용하여 유리 염기의 형태의 화학식 I의 화합물의 제조; 및 네번째, 단독으로 또는 혼합물의 형태로 공정에서 직접적으로 재사용될 수 있고, 따라서 환경 연관성을 매우 작게 유지할 수 있는 용매의 사용이다. The advantages of the process according to the invention are, firstly, the direct separation and very good yield of the compounds of formula I of high purity as the free base; Second, the selected reaction conditions allow the oxime and tosylation reactions to be carried out in a continuous process which always results in only a small amount of the intermediate of formula (XI) from a safety point of view and does not separate the dangerous acetylpyridine tosyl oxime as a solid from a safety point of view. After a short delay, directly converting to an amino ketal of formula I, which is not dangerous from a safety point of view in a continuous device; Third, preparation of the compound of formula I in the form of a free base using a method suitable for industrial scale of high purity (at least 97%) and yield (at least 75% based on the acetylpyridine used); And fourth, the use of a solvent which can be directly reused in the process either alone or in the form of a mixture, thus keeping the environmental relevance very small.
실시예 1:Example 1:
1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄의 제조, 방법 1Preparation of 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane, Method 1
1(a) 반응기에서, 40% 하이드록실암모늄 클로라이드 용액 174g, 3-아세틸피리딘 121g 및 33% 수산화나트륨 용액 245g을 15 내지 25℃에서 3성분 계량으로 반응시킨다. 수득된 3-아세틸피리딘 옥심 나트륨 염 용액을 메틸트리부틸암모늄 클로라이드 2g와 반응시킨다.In reactor 1 (a), 174 g of 40% hydroxylammonium chloride solution, 121 g of 3-acetylpyridine and 245 g of 33% sodium hydroxide solution are reacted in a three component metering at 15 to 25 ° C. The obtained 3-acetylpyridine oxime sodium salt solution is reacted with 2 g of methyltributylammonium chloride.
1(b) 그 후, 이 용액을 35 내지 38℃의 내부 온도에서 연속 공정(부분적으로 변환되는 정적혼합기를 경유하는 재순환 방법)으로 p-톨루엔설포닐 클로라이드 193g 및 톨루엔 655g의 용액과 반응시킨다. 그 후, 수득된 2상 혼합물을 분리 영역을 통과시키고 용매 상을 수성 상과 분리한다.1 (b) The solution is then reacted with a solution of 193 g of p-toluenesulfonyl chloride and 655 g of toluene in a continuous process (recycling method via a partially converted static mixer) at an internal temperature of 35 to 38 ° C. The resulting biphasic mixture is then passed through a separation zone and the solvent phase is separated from the aqueous phase.
1(c) 용매 상을 초기 충전된 메탄올(제1 용매 증류로부터의 또는 메탄올/톨루엔 혼합물, 하기 참조) 940g 및 30% 나트륨 메톡사이드 용액 216g 용액으로 직접적으로 가도록 한다. 온도를 20 내지 40℃의 범위로 유지한다. 반응 용액을 추가의 5 내지 10시간 동안 계속적으로 반응시키도록 한다. 메탄올을 70 내지 90℃ 및 대기압에서 톨루엔(제1 용매 증류)과 함께 아제트로프 혼합물로서 반응 혼합물로부터 증류시킨다. 아제크로프 용매 혼합물을 상기 상기 기재된 반응(상기 참조)로 재순환 시킬 수 있다. 증류 후, 증류 잔여물을 25℃로 냉각한 후, p-톨루엔설폰산 나트륨 염을 여과하고 톨루엔 85g으로 세척한다. 그 후, 120 내지 130℃에서 여과물을 감압(약 100 내지 200mbar)하에 증류로 농축시킨다. 그 후, 폴리에틸렌 글리콜 600 10 내지 20g을 증류 잔여물에 가하고 1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄을 1 내지 10mbar 및 100 내지 160℃의 내부 증발기 온도에서 무수 액체로서 짧은 컬럼을 경유하여 증류한다. 1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄 157.3g을 순도 98 내지 99%(적정, HPLC-MS 및 NMR의 방법으로 참조 표준과 비교하여 측정)으로 수득한다. 이는 사용된 3-아세틸피리딘을 기준으로 하여, 이론치의 수율 85%에 해당한다. The 1 (c) solvent phase is allowed to go directly to 940 g of initially charged methanol (from the first solvent distillation or methanol / toluene mixture, see below) and 216 g of 30% sodium methoxide solution. The temperature is maintained in the range of 20 to 40 ° C. The reaction solution is allowed to continue to react for an additional 5-10 hours. Methanol is distilled from the reaction mixture as an azetrope mixture with toluene (first solvent distillation) at 70-90 ° C. and atmospheric pressure. The azecrope solvent mixture can be recycled to the reaction described above (see above). After distillation, the distillation residue is cooled to 25 ° C., then the p-toluenesulfonic acid sodium salt is filtered off and washed with 85 g of toluene. The filtrate is then concentrated by distillation under reduced pressure (about 100-200 mbar) at 120-130 ° C. Thereafter, 10 to 20 g of polyethylene glycol 600 was added to the distillation residue and 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane was anhydrous at an internal evaporator temperature of 1 to 10 mbar and 100 to 160 ° C. Distillate via a short column as a liquid. 157.3 g of 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane are obtained with a purity of 98-99% (measured compared to the reference standard by titration, HPLC-MS and NMR methods). This corresponds to a theoretical yield of 85% based on the 3-acetylpyridine used.
실시예 2:Example 2:
1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄의 제조, 방법 2Preparation of 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane, Method 2
2(a) 반응기에서, 40% 하이드록실암모늄 클로라이드 용액 174g , 3-아세틸피리딘 121g 및 33% 수산화나트륨 용액 245g을 15 내지 25℃에서 3성분 계량으로 반응시킨다. 수득된 3-아세틸피리딘 옥심 나트륨 염 용액을 메틸트리부틸암모늄 클로라이드 2g와 반응시킨다. In reactor 2 (a), 174 g of 40% hydroxylammonium chloride solution, 121 g of 3-acetylpyridine and 245 g of 33% sodium hydroxide solution are reacted in a three component metering at 15 to 25 ° C. The obtained 3-acetylpyridine oxime sodium salt solution is reacted with 2 g of methyltributylammonium chloride.
2(b) 그 후, 이 용액을 35 내지 38℃의 내부 온도에서 연속 공정(부분적으로 변환되는 정적혼합기를 경유하는 재순환 방법)으로 p-톨루엔설포닐 클로라이드 193g 및 톨루엔 655g의 용액과 반응시킨다. 그 후, 수득된 2상 혼합물을 분리 영역을 통과시키고 용매 상을 수성 상과 분리한다.2 (b) The solution is then reacted with a solution of 193 g of p-toluenesulfonyl chloride and 655 g of toluene at a continuous process (recycling method via a partially converted static mixer) at an internal temperature of 35 to 38 ° C. The resulting biphasic mixture is then passed through a separation zone and the solvent phase is separated from the aqueous phase.
2(c) 용매 상을 초기 충전된 메탄올(제1 용매 증류로부터의 또는 메탄올/톨루엔 혼합물, 하기 참조) 940g 및 수산화나트륨 48g 용액으로 직접적으로 가도록 한다. 온도를 20 내지 40℃의 범위로 유지한다. 반응 용액을 추가의 5 내지 10시간 동안 계속적으로 반응시키도록 한다. 메탄올을 톨루엔(제1 용매 증류)과 함께 아제트로프 혼합물로서 반응 혼합물로부터 증류시킨다. 아제크로프 용매 혼합물을 상기 상기 기재된 반응(상기 참조)로 재순환 시킬 수 있다. 증류 후, 증류 잔여물을 25℃로 냉각한 후, p-톨루엔설폰산 나트륨 염을 여과하고 톨루엔 85g으로 세척한다. 그 후, 120 내지 130℃에서 여과물을 감압(약 100 내지 200mbar)하에 증류로 농축시킨다. 그 후, 폴리에틸렌 글리콜 600 10 내지 20g을 증류 잔여물에 가하고 1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄을 1 내지 10mbar 및 100 내지 160℃의 내부 증발기 온도에서 무수 액체로서 짧은 컬럼을 경유하여 증류한다. 1-(3-피리디닐)-1,1-디메톡시-2-아미노에탄 148g을 순도 98 내지 99%(적정, HPLC-MS 및 NMR의 방법으로 참조 표준과 비교하여 측정)으로 수득한다. 이는 사용된 3-아세틸피리딘을 기준으로 하여, 이론치의 수율 85%에 해당한다. 2 (c) The solvent phase is taken directly to 940 g of initially charged methanol (from the first solvent distillation or to a methanol / toluene mixture, see below) and a 48 g solution of sodium hydroxide. The temperature is maintained in the range of 20 to 40 ° C. The reaction solution is allowed to continue to react for an additional 5-10 hours. Methanol is distilled from the reaction mixture as an azetrope mixture with toluene (first solvent distillation). The azecrope solvent mixture can be recycled to the reaction described above (see above). After distillation, the distillation residue is cooled to 25 ° C., then the p-toluenesulfonic acid sodium salt is filtered off and washed with 85 g of toluene. The filtrate is then concentrated by distillation under reduced pressure (about 100-200 mbar) at 120-130 ° C. Thereafter, 10 to 20 g of polyethylene glycol 600 was added to the distillation residue and 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane was anhydrous at an internal evaporator temperature of 1 to 10 mbar and 100 to 160 ° C. Distillate via a short column as a liquid. 148 g of 1- (3-pyridinyl) -1,1-dimethoxy-2-aminoethane are obtained with a purity of 98-99% (measured compared to the reference standard by titration, HPLC-MS and NMR methods). This corresponds to a theoretical yield of 85% based on the 3-acetylpyridine used.
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10305391.3 | 2003-02-11 | ||
DE10305391A DE10305391A1 (en) | 2003-02-11 | 2003-02-11 | Preparation of 1-(pyridinyl)-1,1-dialkoxy-1-aminoethane derivatives involves reacting acetylpyridine tosyl oxime with mixture of alkali metal alkoxide or hydroxide or alkaline earth metal alkoxide or hydroxide with alcohol |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050101205A true KR20050101205A (en) | 2005-10-20 |
KR101114893B1 KR101114893B1 (en) | 2012-03-06 |
Family
ID=32730947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057014743A KR101114893B1 (en) | 2003-02-11 | 2004-01-27 | - Process for preparing pyridine-substituted amino ketal derivatives |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1601648A2 (en) |
JP (1) | JP4709741B2 (en) |
KR (1) | KR101114893B1 (en) |
CN (1) | CN100393701C (en) |
AR (1) | AR043132A1 (en) |
AU (1) | AU2004212038B2 (en) |
BR (1) | BRPI0407349A (en) |
CA (1) | CA2514255C (en) |
CO (1) | CO5690583A2 (en) |
DE (1) | DE10305391A1 (en) |
HK (1) | HK1086007A1 (en) |
IL (1) | IL169900A (en) |
MX (1) | MXPA05007961A (en) |
NO (1) | NO332353B1 (en) |
NZ (1) | NZ541735A (en) |
PL (1) | PL376654A1 (en) |
RU (1) | RU2336271C2 (en) |
TW (1) | TWI316054B (en) |
WO (1) | WO2004072026A2 (en) |
ZA (1) | ZA200505298B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115477926B (en) * | 2022-09-15 | 2024-06-25 | 江苏科技大学 | Phase change material and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4746669A (en) * | 1985-12-23 | 1988-05-24 | Merck & Co., Inc. | Substituted thiazoles as immunoregulants |
US4798841A (en) * | 1987-03-31 | 1989-01-17 | Warner-Lambert Company | Tetrahydropyridine oxime cholinergic agents and method of treatment |
US5792871A (en) * | 1996-07-22 | 1998-08-11 | Merck & Co., Inc. | Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide |
FR2780973B1 (en) * | 1998-07-09 | 2001-10-05 | Hoechst Marion Roussel Inc | PROCESS FOR THE PREPARATION OF 4- (3-PYRIDINYL) -1H-IMIDAZOLE, AND THE INTERMEDIATES USED |
-
2003
- 2003-02-11 DE DE10305391A patent/DE10305391A1/en not_active Withdrawn
-
2004
- 2004-01-27 JP JP2006501606A patent/JP4709741B2/en not_active Expired - Fee Related
- 2004-01-27 RU RU2005128281/04A patent/RU2336271C2/en not_active IP Right Cessation
- 2004-01-27 CA CA2514255A patent/CA2514255C/en not_active Expired - Fee Related
- 2004-01-27 MX MXPA05007961A patent/MXPA05007961A/en active IP Right Grant
- 2004-01-27 WO PCT/EP2004/000640 patent/WO2004072026A2/en active Application Filing
- 2004-01-27 AU AU2004212038A patent/AU2004212038B2/en not_active Ceased
- 2004-01-27 BR BR0407349-5A patent/BRPI0407349A/en not_active IP Right Cessation
- 2004-01-27 NZ NZ541735A patent/NZ541735A/en not_active IP Right Cessation
- 2004-01-27 CN CNB2004800034784A patent/CN100393701C/en not_active Expired - Fee Related
- 2004-01-27 PL PL376654A patent/PL376654A1/en not_active Application Discontinuation
- 2004-01-27 EP EP04705409A patent/EP1601648A2/en not_active Withdrawn
- 2004-01-27 KR KR1020057014743A patent/KR101114893B1/en not_active IP Right Cessation
- 2004-02-09 TW TW093102879A patent/TWI316054B/en not_active IP Right Cessation
- 2004-02-09 AR ARP040100398A patent/AR043132A1/en not_active Application Discontinuation
-
2005
- 2005-06-30 ZA ZA200505298A patent/ZA200505298B/en unknown
- 2005-07-26 IL IL169900A patent/IL169900A/en not_active IP Right Cessation
- 2005-08-09 CO CO05078811A patent/CO5690583A2/en active IP Right Grant
- 2005-09-07 NO NO20054167A patent/NO332353B1/en not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106012A patent/HK1086007A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200505298B (en) | 2008-01-30 |
RU2336271C2 (en) | 2008-10-20 |
JP2006518716A (en) | 2006-08-17 |
WO2004072026B1 (en) | 2004-11-18 |
CA2514255C (en) | 2012-01-24 |
NZ541735A (en) | 2008-06-30 |
HK1086007A1 (en) | 2006-09-08 |
TWI316054B (en) | 2009-10-21 |
CN1747932A (en) | 2006-03-15 |
NO20054167D0 (en) | 2005-09-07 |
AU2004212038B2 (en) | 2010-11-25 |
WO2004072026A3 (en) | 2004-09-30 |
IL169900A (en) | 2010-12-30 |
DE10305391A1 (en) | 2004-08-19 |
NO332353B1 (en) | 2012-09-03 |
NO20054167L (en) | 2005-10-31 |
AR043132A1 (en) | 2005-07-20 |
AU2004212038A1 (en) | 2004-08-26 |
WO2004072026A2 (en) | 2004-08-26 |
CO5690583A2 (en) | 2006-10-31 |
BRPI0407349A (en) | 2006-01-10 |
CA2514255A1 (en) | 2004-08-26 |
PL376654A1 (en) | 2006-01-09 |
CN100393701C (en) | 2008-06-11 |
RU2005128281A (en) | 2006-02-10 |
IL169900A0 (en) | 2007-07-04 |
JP4709741B2 (en) | 2011-06-22 |
KR101114893B1 (en) | 2012-03-06 |
EP1601648A2 (en) | 2005-12-07 |
MXPA05007961A (en) | 2005-09-20 |
TW200504020A (en) | 2005-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8288553B2 (en) | Method for preparing disubstituted piperidine and intermediates | |
US20060205987A1 (en) | Process for preparing alkyl chlorides | |
US6495685B1 (en) | Process for preparing piperazine derivatives | |
KR100551926B1 (en) | Process for producing cilostazol | |
KR20050101205A (en) | Process for preparing pyridine-substituted amino ketal derivatives | |
US10053420B2 (en) | Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine | |
US6916934B2 (en) | Process for preparing pyridine-substituted amino ketal derivatives | |
KR0172014B1 (en) | Process and intermediate products for preparing hydroxylamine-ethers and their salts | |
JP5078211B2 (en) | Method for producing heterocyclic compound | |
KR100586671B1 (en) | Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds | |
US20210070710A1 (en) | Method for producing quinolin-4(1h)-one derivative | |
EP2650282B1 (en) | Process for producing substituted methylamine compound and triazine derivative | |
EP2835371B1 (en) | Industrial method for manufacturing high-purity methiozoline | |
JPH09104667A (en) | Production of o-nitrobenzonitrile | |
EA006653B1 (en) | Method for producing 2-chloromethylphenyl acetic acid derivatives | |
WO2008023205A1 (en) | Process for the manufacture of hi-6 dimethanesulfonate | |
US5998614A (en) | Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process | |
US5326911A (en) | Process for the preparation of ortho-amides | |
CN115806530A (en) | Preparation method of isoxadifen | |
US8809590B2 (en) | Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol | |
JPH06228103A (en) | New octahydroacridine derivative and its production | |
CN117551038A (en) | Synthesis method for promoting preparation of 4-bromo-7-methyl-1H-indazole ring by boric acid | |
JPH0456029B2 (en) | ||
US20200262848A1 (en) | Novel process for the preparation tavaborole and its intermediates | |
EP0092903A2 (en) | Process for preparing 2-pyridylalkyl amines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |